Health

Global Cord Blood Corporation Files Its Annual Report on Form 20-F

HONG KONG, July 30, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual ...

2020-07-30 04:16 17980

First successful trans-femoral mitral valve repair device DragonFly™ performed in China

HANGZHOU, China, July 29, 2020 /PRNewswire/ -- On July 23, 2020, Professor Jian'an Wang's team at the Second Affiliated Hospital of Zhejiang University School of Medicine successfully completed the world's first human clinical application of the transcatheter mitral valve repair system (Dragon...

2020-07-29 23:00 2361

From The Alzheimer's Association International Conference 2020: The Impact Of COVID-19 And The Global Pandemic On Alzheimer's Research, Long-Term Care And The Brain

CHICAGO, July 29, 2020 /PRNewswire/ -- COVID-19 and the global pandemic have caused significant disruption to all aspects of life including Alzheimer's clinical research worldwide. The impact of COVID, quarantine, and the resulting fear and isolation are causing problems, but also driving unprece...

2020-07-29 23:00 3348

SEKISUI Diagnostics Invests £14.4 Million in cGMP Biopharma CDMO Capacity

BURLINGTON, Mass., July 29, 2020 /PRNewswire/ -- Sekisui announces the decision to invest £14.4 Million in its biopharma CDMO business aimed atcGMP microbial capacity expansion at the existing site in Maidstone, Kent to be completed by the second half of 2022. This investment follows the investme...

2020-07-29 21:00 3323

INOVIO Receives Orphan Drug Designation From U.S. FDA for DNA Medicine INO-3107 To Treat Rare Disease Recurrent Respiratory Papillomatosis (RRP)

PLYMOUTH MEETING, Pennsylvania, July 29, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO) today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for INO-3107, its DNA medicine being evaluated in a Phase 1/2 trial for treatment of recurrent respiratory papillomat...

2020-07-29 19:30 4353

DriWay Technologies Commences Bomb Shelter Pilot Project with Korean Government

The Daejeon City Government will use DriWay's dehydration devices, starting in a key bomb shelter, to remove invasive moisture and improve air safety. NEW YORK, July 29, 2020 /PRNewswire/ -- The Republic of Korea's Daejeon City Government has commissioned DriWay Technologies to install its de...

2020-07-29 18:00 2510

BIO Asia-Taiwan 2020 Concludes Successfully

TAIPEI, July 29, 2020 /PRNewswire/ -- BIO Asia-Taiwan 2020 International Conference and Exhibition, the world's first combined onsite plus online biotechnology conference, closed onJuly 26. Held in Taipei, from July 22 to 26, the event attracted over 5,000 viewers to its online conference, of whi...

2020-07-29 17:35 2764

Procare HK Introduces Internationally Certified Made-in-HK Masks - Let's Fight the Virus Together

HONG KONG, July 29, 2020 /PRNewswire/ -- As the Hong Kong public faces a third wave of the COVID-19 epidemic, masks are one of the best prevention tools against this public health threat. Procare HK, aHong Kong manufacturer of high-quality masks designed to prevent splatter, sprays, and airborne ...

2020-07-29 17:06 4260

Consulcesi: "Covid-19 The Virus Of Fear" An Italian Movie Regarding The Lesson Learned From The Pandemic

Science and cinema: Consulcesi presents the innovative model made in Italy for continuingeducation in medicine and disassembling fake news ROME, July 29, 2020 /PRNewswire/ -- "Will we be able to learn anything from all this?" The movietrailer  of "Covid-19 The Virus...

2020-07-29 17:00 4307

New Findings from AAIC Indicated Brain-Gut Axis to be the New Breakthrough in the Research Field of Alzheimer's Disease

SHANGHAI, July 29, 2020 /PRNewswire/ -- Alzheimer's disease has been an unsolved puzzle for scientists since the first patient was found over 100 years ago. Different theories like cholinergic hypothesis, amyloid cascade hypothesis, and tau protein hypothesis have made progress in research but f...

2020-07-29 15:28 1558

DAVID LAYER, a fashion brand specializing in tailored suits in Moriyama, Shiga Prefecture, has donated face masks made from excess material left over from suits and shirts

MORIYAMA, Japan, July 29, 2020 /PRNewswire/ -- DAVID LAYER, a COLOR Inc. custom suits brand located in Moriyama, Shiga Prefecture (CEO:Tomohiko Banno), donated some 1,000 original design facemasks to Japanese schools in 6 countries around the world. By joining in the fight against COVID-19, these...

2020-07-29 11:00 3895

Celltrion Selects Movilitas for Serialization and Traceability Implementations to Ensure Supply Chain Integrity and Compliance

Project delivers a combined solution for end-to-end visibility in EU, Korea and U.S. markets COLUMBIA, Maryland, July 29, 2020 /PRNewswire/ -- Movilitas, a technology leader delivering the next generation of solutions and consulting services across multiple industries to advance smart supply cha...

2020-07-29 09:38 2543

Atomo Diagnostics and Access Bio partner to expand access to COVID-19 blood-based rapid testing in North America

SYDNEY, July 29, 2020 /PRNewswire/ -- Atomo has announced that it has signed a binding agreement with US-based diagnostics specialist Access Bio Inc. (KOSDAQ: 950130) (Access Bio) that will see Atomo supply its unique, integrated rapid diagnostic test (RDT) devices to Access Bio for use with its ...

2020-07-29 08:47 2499

Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets

SHANGHAI and NEWYORK, July 28, 2020 /PRNewswire/ -- Viva Biotech Holdings (1873.HK) and Schrödinger, Inc. (Nasdaq: SDGR) today announced a strategic collaboration to expand the reach of structure-based drug discovery by generatingde novo crystal structures of high-value targets. Under the terms ...

2020-07-29 07:00 10889

Oscotec to Use CDD Vault to Manage Its Chemistry and Biological Research Data

The company selected the platform to help streamline its drug discovery data management process SEONGNAM-SI, South Korea and BURLINGAME, California, July 29, 2020 /PRNewswire/ -- Oscotec, a Korean biotech company engaged in the clinical stage discovery of novel drug candidates for unmet needs, a...

2020-07-29 07:00 4963

From the Alzheimer's Association International Conference 2020: a Blood Test for Alzheimer's? Markers for tau Take us a Step Closer

CHICAGO, July 29, 2020 /PRNewswire/ -- A simple blood test for Alzheimer's would be a great advance for individuals with — and at risk for — the disease, families, doctors and researchers. At the Alzheimer's Association International Conference® (AAIC®) 2020, scientists reported results of ...

2020-07-29 00:30 3978

Jubilant Biosys Limited announces the merger with Jubilant Chemsys Limited

BENGALURU, India, July 28, 2020 /PRNewswire/ -- Jubilant Biosys Limited ("Biosys"), a wholly owned subsidiary of Jubilant Life Sciences Limited, today announced completion of the merger with its sister company Jubilant Chemsys Limited, based in Noida,India. The combined entities will now operate ...

2020-07-28 20:27 4365

I-Mab Drives Commercialization Strategy with Appointment of Ivan Yifei Zhu as Chief Commercial Officer

SHANGHAI and GAITHERSBERG, Md., July 28, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the appointment of Mr.Ivan Yifei Zhu as its Chief Commer...

2020-07-28 20:22 10013

"White Mouse in Water" - Infinitus Develops New Technology of Using Zebrafish for Health Products Screening

GUANGZHOU, China, July 28, 2020 /PRNewswire/ -- Recently, the Chinese Institute of Food Science and Technology (CIFST) brought together experts inBeijing to evaluate the results of a collaborative R&D effort between Infinitus (China) Company Ltd. and Hangzhou Hunter Biotechnology Co., Ltd., named...

2020-07-28 20:00 4242

New Licensing Agreement Accelerates the Development of IACTA Pharmaceuticals' Novel Dry Eye Disease and Allergic Conjunctivitis Treatments in China and Southeast Asia

IRVINE, Calif. and HONG KONG, July 28, 2020 /PRNewswire/ -- IACTA Pharmaceuticals, Inc. ("IACTA" or the "Company") and Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited ("ZKO"), a leadingHong Kong-based pharmaceutical company, today announces they have entered into a definitive license agr...

2020-07-28 17:59 3349
1 ... 658659660661662663664 ... 820